Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy.

Published

Journal Article

AIM: To describe the exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy. An institutional review board-approved protocol for a clopidogrel pharmacogenetic program in a community pharmacy was developed to address feasibility and evaluate the pilot program. STUDY CONCEPT: Subjects taking clopidogrel are asked to participate at the point of medication dispensing. A pharmacist schedules an appointment with subjects to discuss the study and collects a buccal swab sample for CYP2C19 testing. When the results are available, the pharmacist consults with the subject's prescriber regarding test result interpretation and associated recommendations, and schedules a second appointment with the participant to discuss results and review any physician-approved therapeutic changes. The intervention-associated consultation is then billed to the subject's insurance. RESULTS: Subject enrollment has begun. CONCLUSION: Community pharmacists may be valuable partners in pharmacogenetics.

Full Text

Duke Authors

Cited Authors

  • O'Connor, SK; Ferreri, SP; Michaels, NM; Greco, AJ; Viera, AJ; Faruki, H; McLeod, HL; Roederer, MW

Published Date

  • June 2012

Published In

Volume / Issue

  • 13 / 8

Start / End Page

  • 955 - 962

PubMed ID

  • 22676199

Pubmed Central ID

  • 22676199

Electronic International Standard Serial Number (EISSN)

  • 1744-8042

Digital Object Identifier (DOI)

  • 10.2217/pgs.12.67

Language

  • eng

Conference Location

  • England